首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   21274篇
  免费   1339篇
  国内免费   74篇
耳鼻咽喉   333篇
儿科学   1183篇
妇产科学   503篇
基础医学   1857篇
口腔科学   380篇
临床医学   1650篇
内科学   5030篇
皮肤病学   354篇
神经病学   1051篇
特种医学   852篇
外科学   3788篇
综合类   584篇
一般理论   3篇
预防医学   1136篇
眼科学   879篇
药学   1597篇
  1篇
中国医学   110篇
肿瘤学   1396篇
  2023年   151篇
  2022年   243篇
  2021年   781篇
  2020年   420篇
  2019年   617篇
  2018年   721篇
  2017年   502篇
  2016年   515篇
  2015年   529篇
  2014年   824篇
  2013年   1025篇
  2012年   1531篇
  2011年   1390篇
  2010年   918篇
  2009年   723篇
  2008年   1021篇
  2007年   1042篇
  2006年   980篇
  2005年   907篇
  2004年   803篇
  2003年   694篇
  2002年   610篇
  2001年   492篇
  2000年   519篇
  1999年   421篇
  1998年   205篇
  1997年   197篇
  1996年   168篇
  1995年   154篇
  1994年   136篇
  1993年   113篇
  1992年   288篇
  1991年   256篇
  1990年   229篇
  1989年   234篇
  1988年   191篇
  1987年   193篇
  1986年   171篇
  1985年   178篇
  1984年   157篇
  1983年   143篇
  1982年   74篇
  1981年   83篇
  1980年   72篇
  1979年   119篇
  1978年   87篇
  1977年   69篇
  1974年   75篇
  1973年   110篇
  1972年   100篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Demographic projections for hip fragility fractures indicate a rising annual incidence by virtue of a multimorbid, ageing population with more noncommunicable diseases (NCDs). NCDs are characterised by slow progression and long duration ranging from ischaemic cardiovascular disease, cerebrovascular disease, diabetes, chronic obstructive pulmonary disease to various cancers. Management of this disease burden often involves commencing patients on oral anticoagulants to reduce the risk of thromboembolic events. The use of direct oral anticoagulants (DOACs) in clinical practice has increased due to their rapid onset of action, short half-life and predictable anticoagulant effects, without the need for routine monitoring. Safe and timely surgical intervention relies on reversal of anticoagulants. However, the lack of specific evidence-based guidelines for the perioperative management of patients on DOACs with hip fractures has proved challenging; in particular, the accessibility of DOAC-specific assays, justification of the cost-benefit ratio of targeted reversal agents and indications for neuraxial anaesthesia. This has led to potentially avoidable delays in surgical intervention. Following a literature review of the pharmacokinetic and pharmacodynamics of commonly used DOACs in our region including the role of surrogate markers, we propose a systematic, evidence-based guideline to the perioperative management of hip fractures DOACs. We believe this standardised protocol can be easily replicated between hospitals. We recommend that if patients are deemed suitable for a general anaesthesia, with satisfactory renal function, optimal surgical time should be 24 h following the last ingested dose of DOAC.  相似文献   
4.
5.
6.
The growth of online support groups has led to an expression effects paradigm within the health communication literature. Although religious support expression is characterized as a typical subdimension of emotional support, we argue that in the context of a life-threatening illness, the inclusion of a religious component creates a unique communication process. Using data from an online group for women with breast cancer, we test a theoretical expression effects model. Results demonstrate that for breast cancer patients, religious support expression has distinct effects from general emotional support messages, which highlights the need to further theorize expression effects along these lines.  相似文献   
7.
8.
9.
10.
Objective: Acute graft-versus-host disease (aGVHD) is a common and life-threatening complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT). The extent to which aGVHD increases inpatient costs associated with allo-HSCT has not been thoroughly evaluated. In this analysis, mortality, hospital length of stay (LOS) and costs associated with aGVHD during allo-HSCT admissions are evaluated.

Methods: This is a retrospective analysis of discharge records from the National Inpatient Sample database for patients receiving allo-HSCT between 1 January 2009 and 31 December 2013. Allo-HSCT discharges with an aGVHD diagnosis were included in the aGVHD group and those without any graft-versus-host disease (GVHD) diagnosis comprised the non-GVHD group. Mortality, LOS and costs were compared between the two groups, as well as within subgroups, including age (<18 vs. ≥18 years) and survival status (alive vs. deceased) at discharge.

Results: Overall, mortality (16.2% vs. 5.3%; p?<?.01), median hospital LOS (42.0 vs. 26.0 days; p?<?.01) and median total costs ($173,144 vs. $98,982; p?<?.01) were significantly increased in patients with aGVHD versus those without GVHD during hospitalizations for allo-HSCT, irrespective of age group. Patients with aGVHD who were <18 years of age had a lower mortality rate but greater hospital LOS and total costs versus patients aged ≥18 years. Patients who died during allo-HSCT hospitalization had longer LOS and incurred greater costs than those who survived in both the aGVHD and non-GVHD groups.

Conclusion: Occurrence of aGVHD during allo-HSCT admissions resulted in a tripling of the mortality rate and a near doubling of hospital LOS and total costs. In addition, death during allo-HSCT hospitalizations was associated with greater healthcare utilization and costs. Effectively mitigating aGVHD may improve survival and substantially reduce hospital LOS and costs for allo-HSCT.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号